Skip to main content
. 2021 Jan 23;11(5):1437–1462. doi: 10.1016/j.jcmgh.2021.01.009

Figure 12.

Figure 12

Sox9 expression in BECs is maintained by Yap. (A) Verteporfin treatment does not impact organoid morphology (scale bar = 50 μm) but (B) results in significant down-regulation of Sox9 and established BEC Yap targets, Cyr61 and Klf6, whereas Gadd45b is unaffected (∗ indicates significance, P < .05; ∗∗ indicates significance, P ≤ .01, unpaired t test).